Literature DB >> 7000410

Bacteremia in patients with cystic fibrosis.

M M McCarthy, M H Rourk, A Spock.   

Abstract

Bacteremia in patients with cystic fibrosis (CF) has not been previously reported, a fact probably attributable to activated systemic immunity in the presence of chronic bronchopulmonary infection. We have observed two CF patients under a year of age with documented bacteremia, and a teen-aged patient with autopsy evidence of premortem bacteremia. Organisms were Staphylococcus aureus, Serratia marcescens, and Pseudomonas aeruginosa, having presumably spread from the lower respiratory tract in both patients. None of the patients had historical or laboratory evidence of immunodeficiency. The true incidence of bacteremia in CF patients is unknown, and the circumstances under which it occurs have not yet been defined.

Entities:  

Mesh:

Year:  1980        PMID: 7000410     DOI: 10.1177/000992288001901106

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  9 in total

1.  The effects of purified 25-kDa lipase from a clinical isolate of Pseudomonas cepacia in the lungs of rats.

Authors:  M K Lonon; D E Woods; D C Straus
Journal:  Curr Microbiol       Date:  1992-08       Impact factor: 2.188

2.  Hepatic abscess and cystic fibrosis.

Authors:  G J Canny; E A Roberts; P Liu; J Reisman; H Levison
Journal:  Postgrad Med J       Date:  1988-10       Impact factor: 2.401

3.  Lung abscess in cystic fibrosis.

Authors:  G J Canny; J E Marcotte; H Levison
Journal:  Thorax       Date:  1986-03       Impact factor: 9.139

Review 4.  Cystic fibrosis.

Authors:  M E Hodson
Journal:  Postgrad Med J       Date:  1984-03       Impact factor: 2.401

5.  Functional activity of peripheral mononuclear cells in cystic fibrosis: antibodies and plaque formation.

Authors:  M Götz; C C Zielinski; R Ahmad; M Eibl
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

6.  Heart and lung transplantation in patients with end stage lung disease.

Authors:  A Penketh; T Higenbottam; M Hakim; J Wallwork
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-01

7.  Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis.

Authors:  A Penketh; M E Hodson; H Gaya; J C Batten
Journal:  Thorax       Date:  1984-04       Impact factor: 9.139

Review 8.  Cystic fibrosis. Infection and immunity to Pseudomonas.

Authors:  R U Sorensen; R L Waller; J D Klinger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

9.  A Novel Pathogenic Variant of the CFTR Gene in a Patient with Cystic Fibrosis Phenotype-c.4096A > T.

Authors:  Ahmet Burak Arslan; Ayşe Gül Zamani; Sevgi Pekcan; Mahmut Selman Yıldırım
Journal:  J Pediatr Genet       Date:  2019-08-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.